Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Quality Index
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Quality Index of -1.95x as of September 2024. Operating cash flow of CN¥-5.53 Million is below net income of CN¥2.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688068 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Hotgen Biotech Co Ltd Cash Flow Quality Index (2016–2023)
Historical Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Beijing Hotgen Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd (2016–2023)
Year-by-year earnings quality comparison for Beijing Hotgen Biotech Co Ltd. For live market cap and the full company financial profile, see 688068 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.69x | CN¥-25.39 Million | CN¥15.05 Million | ▼ -259.4% |
| 2022 | 1.06x | CN¥978.75 Million | CN¥925.12 Million | ▼ -11.9% |
| 2021 | 1.20x | CN¥2.64 Billion | CN¥2.20 Billion | ▼ -18.8% |
| 2020 | 1.48x | CN¥164.62 Million | CN¥111.30 Million | ▲ +157.7% |
| 2019 | 0.57x | CN¥19.37 Million | CN¥33.75 Million | ▼ -49.7% |
| 2018 | 1.14x | CN¥55.04 Million | CN¥48.19 Million | ▲ +49.7% |
| 2017 | 0.76x | CN¥22.95 Million | CN¥30.07 Million | ▼ -51.7% |
| 2016 | 1.58x | CN¥45.54 Million | CN¥28.80 Million | — |